There is an increasing trend towards conducting non-GLP exploratory toxicology studies in drug discovery to provide clues to a drug candidate’s potential toxicity prior to initiating preclinical toxicology programs. Conducting exploratory toxicology studies can minimize the risk of failure during preclinical studies by providing information on a drug candidate’s toxicology risks and assisting with the design of GLP toxicology studies.
At IITRI, our highly experienced PhD, DABT study directors can assist with the design of a non-GLP exploratory toxicology study customized to the requirements of your program.
Non-GLP toxicology studies in drug discovery include:
- Single and repeat dose range finding toxicology
- Acute, subchronic and chronic toxicology
Contact Us to find out how exploratory toxicology studies can de-risk your drug development program.